Gossamer Bio, Inc. (GOSS)
About Gossamer Bio, Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $48.5M
- Net income
- -$170.4M
- Total assets
- $172.2M
- Market cap
- $41.1M
- Operating margin
- -52.2%
- Net margin
- -49.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $114.7M
- Operating expenses
- $174.6M
- Operating income
- -$59.9M
- Income tax
- $893.0K
- Net income
- -$56.5M
- EPS (basic)
- $-0.25
- EPS (diluted)
- $-0.25
Balance sheet
- Total assets
- $315.3M
- Current assets
- $309.9M
- Total liabilities
- $285.8M
- Current liabilities
- $45.0M
- Shareholders’ equity
- $29.5M
Cash flow
- Operating cash flow
- -$3.5M
- Investing cash flow
- $29.0M
- Financing cash flow
- -$11.5M
- Net cash flow
- $14.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $41.1M
- EPS (diluted)
- $-0.25
- Shares outstanding
- 293.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 8, 2019
Gossamer Bio, Inc. (GOSS) Stock Price
- Reported a net loss of $170.4M in FY2025.
- Trading 96% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Gossamer Bio, Inc..
Write a review
News about Gossamer Bio, Inc.
News & sentiment via Polygon.io
Gossamer Bio, Inc.: frequently asked questions
Is Gossamer Bio, Inc. an American company?
Gossamer Bio, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Gossamer Bio, Inc. headquartered?
Gossamer Bio, Inc. is headquartered in San Diego, California, United States.
Is Gossamer Bio, Inc. publicly traded?
Yes — Gossamer Bio, Inc. is a publicly traded company. Its stock trades under the ticker symbol GOSS on the NASDAQ.
What does Gossamer Bio, Inc. do?
Gossamer Bio, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
